The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.55
Bid: 8.50
Ask: 8.60
Change: -0.46 (-5.31%)
Spread: 0.10 (1.176%)
Open: 8.45
High: 8.56
Low: 8.20
Prev. Close: 8.66
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IsraFirst Regulatory Approval for Cultivated Beef

18 Jan 2024 07:00

RNS Number : 0724A
Agronomics Limited
18 January 2024
 

 

 18 January 2024

 Agronomics Ltd

("Agronomics" or the "Company")

 Israel Awards the World's First Regulatory Approval for Cultivated Beef

 

Agronomics (LON: ANIC), a leading listed company in cellular agriculture, is pleased to announce that the Israeli Ministry of Health (IMOH) has granted regulatory approval for the world's first commercial sale of cultivated beef.

Agronomics would like to congratulate Aleph Farms on becoming the first company in the world to gain regulatory approval for its cultivated beef product after the IMOH issued a 'no questions' letter, which allows the company to commercialise its products in Israel. Aleph Farms has also filed for regulatory approval in Singapore, Switzerland, the UK and the US, and is advancing its applications in other markets.

Agronomics is aware of multiple companies, including those within its portfolio, that are expecting regulatory approvals for cultivated meat and seafood products across several markets. Meanwhile, Vow Food is in the middle of a consultation process after its cultured quail was cleared as safe to eat by Food Standards Australia and New Zealand in December 2023. 

These announcements follow Upside Foods and Good Meat, which received regulatory approval for their cultivated chicken products in the US last year.

Jim Mellon, Executive Chairman of Agronomics commented:

"This approval is another significant step forward for our industry and shows the commitment among an increasing number of jurisdictions to find more sustainable production methods to meet the increasing global demand for protein. We look forward to seeing some of Agronomics' portfolio companies achieving this significant milestone in the near future."  

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 24 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5?.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

 

For further information please contact:

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Securities Plc

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen (Head of Equities)

Giles Balleny

Michael Johnson

Lucy Williams

Charles Goodfellow

Ed Orlebar

Alistair Walker

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

+44 (0) 20 7930 0777

+44 (0) 7738 724 630

agronomics@tbcardew.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAMZGMMLNZGDZM
Date   Source Headline
9th Dec 20207:00 amRNSInvestment in CellX
7th Dec 20201:00 pmRNSPortfolio Update: Mosa Meat
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO
1st Apr 20207:00 amRNSFurther investment in Rebellyous Foods
31st Mar 202010:56 amRNSSubscription of US$2,999,996 in Tropic Biosciences
13th Mar 20207:00 amRNSPortfolio Company Update: Foods United
10th Mar 20207:00 amRNSInvestment of US$ 500,000 in GALY CO.
27th Feb 20207:00 amRNSPortfolio Company BlueNalu Announces Financing
13th Feb 20207:00 amRNSAdditional Investment of US$1 Million in VitroLabs
12th Feb 20207:00 amRNSInvestment of US$3million in Foods United
4th Feb 20201:04 pmRNSResult of AGM
31st Jan 20204:42 pmRNSHolding(s) in Company
28th Jan 20203:58 pmRNSHolding(s) in Company
24th Jan 20201:00 pmRNSFurther Equity Fundraise of £5.5 million
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSHalf-year Report
27th Dec 201912:30 pmRNSIssue of Equity
20th Dec 20197:00 amRNSInvestment in Meatable BV
19th Dec 20197:00 amRNSAdditional Participation in BlueNalu Fundraise
18th Dec 20197:00 amRNSInvestment in LegenDairy Foods GmbH
16th Dec 20194:02 pmRNSHolding(s) in Company
16th Dec 20193:33 pmRNSHolding(s) in Company
12th Dec 20196:01 pmRNSHolding(s) in Company
11th Dec 201912:00 pmRNSInvestment in Oritain Global Limited
9th Dec 20193:00 pmRNSEquity Fundraise Closes at £7.7 million
6th Dec 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.